GENERATE BIOMEDICINES INC
Institutional coverage
46 13F filers hold $GENB.
13F holders
46
Insider buys · 90d
0
Congress · 90d
0
Smart Money · top-200 alpha cohort
2 holders · Q1 2026Fewer than 3 top-performer holders hold this ticker — not enough signal for a Smart-Money commentary this week. The institutional holders table below shows the full picture.
01
Nikko Asset Management Americas, Inc.
0.01% held
α +22.1pts
02
Citigroup Inc.
0.00% held
α +26.3pts
Smart Money shows holdings from our Top-Performer cohort — the 200 highest-alpha manager_13f funds in our universe. Position weight (current quarter) and QoQ delta versus prior quarter. α is the manager's annual alpha vs benchmark.
Institutional holders
Top 10 of 46 · Source: 13F-HR01
Peak6 LLC
67.44% of portfolio
62,673,117 sh
02
TB Capital Gestao de Recursos Ltda.
—
3,938,786 sh
03
Mpm Asset Management LLC
3.59% of portfolio
3,888,852 sh
04
Meixler Investment Management, Ltd.
1.50% of portfolio
3,592,999 sh
05
Shapiro Capital Management LLC
21.33% of portfolio
1,722,210 sh
06
Wynnefield Capital Inc.
0.10% of portfolio
1,423,602 sh
07
Fuller & Thaler Asset Management, Inc.
0.76% of portfolio
1,111,100 sh
08
New South Capital Management Inc.
0.06% of portfolio
833,325 sh
09
GSG Advisors LLC
0.26% of portfolio
736,104 sh
10
Confluence Investment Management LLC
0.02% of portfolio
500,000 sh
Insider activity · last 90 days
No insider activity
No Form 4 filings on record for $GENB in the recent window.
Congress trades · last 90 days
No Congress trades
No STOCK Act filings reference $GENB in the recent window.
Source data: SEC EDGAR · 13F-HR · Form 4 · U.S. House Clerk PTR (disclosures-clerk.house.gov) · Senate eFD (senate.gov) · Last refreshed 07:20 UTC.